FDA.reportPublic FDA data

CRE AM2ATE Knight Seahorse

Manufacturer
J2D INTERNATIONAL | B&B KOREA CO LTD
Effective date
2017-09-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:52:35

Label at a glance#

ProductCRE AM2ATE Knight Seahorse
Active ingredientNiacinamide, Adenosine
Label structure8 sections

Indications and uses

Uses: Moisturizing cream that improving skin texture by seahorse extract and Re-Dermax, and improving skin tone and wrinkle by Niacinamide and Adenosine.

Dosage and administration

Directions: 1.Take an adequate amount onto your palms after applying toner in the morning and evening, 2.and evenly spread onto the face and neck.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredients: Niacinamide 2.0%, Adenosine 0.04%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: WATER,CAPRYLIC/CAPRIC TRIGLYCERIDE,BUTYLENE GLYCOL,GLYCERIN,SEAHORSE EXTRACT(4.5%),BUTYROSPERMUM PARKII (SHEA) BUTTER,PERSEA GRATISSIMA (AVOCADO) OIL,CETEARYL OLIVATE, CETEARYL ALCOHOL,SORBITAN OLIVATE,DIMETHICONE,CYCLOPENTASILOXANE,BEESWAX,CYCLOHEXASILOXANE,PEG-40 STEARATE,STEARIC ACID,BETAINE,PHENOXYETHANOL,SODIUM POLYACRYLOYLDIMETHYL TAURATE,VEGETABLE OIL,GLYCERYL CAPRYLATE,DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER,HYDROGENATED POLYDECENE,PERFUME,SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL,PAULLINIA CUPANA SEED EXTRACT,CENTELLA ASIATICA EXTRACT,XANTHAN GUM,TOCOPHERYL ACETATE, TRIDECETH-10,SALVIA HISPANICA SEED EXTRACT,OCIMUM BASILICUM (BASIL) FLOWER/LEAF/STEM EXTRACT,AVENA SATIVA (OAT) KERNEL EXTRACT,DISODIUM EDTA,BIFIDA FERMENT LYSATE,SODIUM HYALURONATE,1,2-HEXANEDIOL,HYDROGENATED LECITHIN,CAPRYLYL GLYCOL,CERAMIDE 3,POTASSIUM SORBATE,PHASEOLUS RADIATUS MERISTEM CELL CULTURE EXTRACT,PANAX GINSENG CALLUS CULTURE EXTRACT,DAUCUS CAROTA SATIVA (CARROT) CALLUS CULTURE EXTRACT,CHRYSANTHEMUM INDICUM CALLUS CULTURE EXTRACT,CAMELLIA SINENSIS CALLUS CULTURE EXTRACT,BAMBUSA VULGARIS CALLUS CULTURE EXTRACT,TROPOLONE,RH-OLIGOPEPTIDE-1

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Brightening & Anti wrinkle

WARNINGS

WARNINGS SECTION

Warnings: For external use only

1. If the following symptoms occur while using this product, discontinue use and consult your dermatologist: (1) Red spots, swelling, itching, or irritation (2) If the application area develops the symptoms above after exposure to direct sunlight

2. Do not apply on areas with injuries, eczema, or dermatitis.

3. Storage & Handling (1) Keep the cap closed after use. (2) Keep out of reach of children. (3) Keep away from direct sunlight and extreme high or low temperatures.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

Uses: Moisturizing cream that improving skin texture by seahorse extract and Re-Dermax, and improving skin tone and wrinkle by Niacinamide and Adenosine.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions: 1.Take an adequate amount onto your palms after applying toner in the morning and evening, 2.and evenly spread onto the face and neck.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69958-130-022020-01-31C16284748780-19d75b9d0-6046-f424-e053-dadaa90a57cef7dfcfde-5dde-49bf-a22e-36be056407c2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69958-130-01CRE AM2ATE Knight Seahorse50 mL in 1 CONTAINERCREAM501
69958-130-02CRE AM2ATE Knight Seahorse1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69958-130CRE AM2ATE KNIGHT SEAHORSE (NIACINAMIDE, ADENOSINE) CREAM [J2D INTERNATIONAL]1Legacy NDC, 2 package rows20170927_f7dfcfde-5dde-49bf-a22e-36be056407c2.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69958-13069958-130-01, 69958-130-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
Niacinamide25X51I8RD4ACTIB
AdenosineK72T3FS567ACTIB
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
43f14f5e-aa40-44c9-9149-71776e64ea29f7dfcfde-5dde-49bf-a22e-36be056407c22017-09-27WarningsExact identifier
spl id: 43f14f5e-aa40-44c9-9149-71776e64ea29
spl set id: f7dfcfde-5dde-49bf-a22e-36be056407c2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.